SEYİTLER KİMYA SANAYİ A.Ş. Logo

SEYİTLER KİMYA SANAYİ A.Ş.

Manufacturer of medical plasters, wound dressings, and first-aid tapes.

SEYKM | IS

Overview

Corporate Details

ISIN(s):
TRESEYT00011 (+2 more)
LEI:
789000QODBWOP1OPEQ85
Country:
Türkiye
Address:
Turgutlu 1. OSB 2007 Cad. No:5-7 Turgutlu, 45400 MANİSA

Description

Seyitler Kimya Sanayi A.Ş., established in 1991, is a manufacturer of medical products. The company's portfolio includes a wide range of medical plasters, wound dressings, first-aid tapes, and solid medical wound products, including the plaster-cataplasm group. Operating from a large-scale production campus equipped with modern, high-capacity machinery, the company ensures manufacturing continuity and reliability. Seyitler Kimya emphasizes research and development, focusing on medical adhesive technologies through collaborations with universities and research institutions. This commitment drives the development of innovative and high-performance products for the healthcare sector. The company serves both domestic and international markets through a dedicated network of dealers and distributors.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-11-03 14:53
Kayıtlı Sermaye Tavanı Artırımının Tescili
English 7.5 KB
2023-11-03 14:33
2023 Yılı Olağanüstü Genel Kurul Toplantı Sonucu Hk.
Turkish 308.8 KB
2023-11-03 14:33
2023 Yılı Olağanüstü Genel Kurul Toplantı Sonucu Hk.
Turkish 352.1 KB
2023-11-03 14:33
2023 Yılı Olağanüstü Genel Kurul Toplantı Sonucu Hk.
Turkish 454.5 KB
2023-11-03 14:33
2023 Yılı Olağanüstü Genel Kurul Toplantı Sonucu Hk.
Turkish 241.5 KB
2023-11-03 14:33
2023 Yılı Olağanüstü Genel Kurul Toplantı Sonucu Hk.
Turkish 460.0 KB
2023-11-03 14:33
2023 Yılı Olağanüstü Genel Kurul Toplantı Sonucu Hk.
Turkish 276.2 KB
2023-11-03 14:33
2023 Yılı Olağanüstü Genel Kurul Toplantı Sonucu Hk.
Turkish 1003.5 KB
2023-11-03 14:33
2023 Yılı Olağanüstü Genel Kurul Toplantı Sonucu Hk.
Turkish 15.7 KB
2023-10-30 16:49
Geri Alınan Payların Elden Çıkarılması
Turkish 35.4 KB
2023-10-27 17:13
Financial Report
Turkish 1.7 MB
2023-10-27 17:13
Financial Report
English 2.5 MB
2023-10-27 10:31
30.09.2023 Finansal Raporu Hk.
Turkish 28.2 KB
2023-10-26 17:14
30.09.2023 Sorumluluk Beyanı Hk.
Turkish 21.5 KB
2023-10-26 17:14
30.09.2023 Faaliyet Raporu Hk.
Turkish 1.5 MB

Automate Your Workflow. Get a real-time feed of all SEYİTLER KİMYA SANAYİ A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SEYİTLER KİMYA SANAYİ A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SEYİTLER KİMYA SANAYİ A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.